18 min listen
Inhibition of Ang-2: Potential Effect in AMD Treatment Paradigms
Inhibition of Ang-2: Potential Effect in AMD Treatment Paradigms
ratings:
Length:
14 minutes
Released:
Jun 29, 2020
Format:
Podcast episode
Description
The integration of intravitreal anti-vascular endothelial growth factor therapies into treatment algorithms for the management of neovascular retinal diseases has provided significant visual outcome gains for these patients. The effectiveness of current treatment algorithms varies based on treatment protocol, number of therapy injections, and patient adherence. However, suboptimal responses to therapy along with loss of patient adherence from treatment burden has defined a need for the development of novel treatments and sustained delivery options for the management of neovascular retinal diseases. In this podcast, Dr. Carl Regillo and Dr. Jeffrey Heier discuss inhibition of angiopoietin-2 and its potential effect on current treatment paradigms for the management of neovascular age-related macular degeneration.
Released:
Jun 29, 2020
Format:
Podcast episode
Titles in the series (90)
Dosing Schedules for Emerging Agents Used to Treat nAMD That Require Less Frequent Dosing Than Standard Anti-VEGF Therapy: Dosing Schedules for Emerging Agents Used to Treat nAMD That Require Less Frequent Dosing Than Standard Anti-VEGF Therapy by MedEdTalks - Ophthalmology